MADYSEN WEIGEL: Open Payments
NPI 1295492908 · HAYS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 55 payments from 10 companies in 2025. Trend: 2023 $686 · 2024 $1,036 · 2025 $1,034
Food & beverage: $759Education: $275
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $278 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $157 |
| UCB, Inc. | 13 | $156 |
| ABBVIE INC. | 16 | $154 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Amgen Inc. | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| BioWound Solutions, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: TREMFYA, Bimzelx, SKYRIZI, DUPIXENT, OTEZLA, Sotyktu, BLU-U, RINVOQ.
Industry payments across KS — which companies pay providers there.
